Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) EBT Margin (2020 - 2024)

BioAtla (BCAB) has 2 years of EBT Margin data on record, last reported at 12152.4% in Q2 2021.

  • For Q2 2021, EBT Margin fell 977398.0% year-over-year to 12152.4%; the TTM value through Mar 2022 reached 40662.4%, down 2666358.0%, while the annual FY2024 figure was 641.58%, N/A changed from the prior year.
  • EBT Margin reached 12152.4% in Q2 2021 per BCAB's latest filing, down from 5322.67% in the prior quarter.
  • Across five years, EBT Margin topped out at 1240.45% in Q1 2020 and bottomed at 12152.4% in Q2 2021.